India
Therapeutic Areas
Products
New Introductions
Europe
North America
Russia & CIS
Other International Markets
Product Development
Manufacturing
Contact Us
Quick Links
Company News Coverage
Sustainability Report
NCE Pipeline
Our Values
A best-in-class
regulatory team
India
- New Introductions
Dr. Reddy's launches Supanac® - (Diclofenac potassium)
Dr. Reddy's launches Glimy MP 1 and Glimy MP2.
Dr. Reddy's enters the Dermatology topical steroid market with the launch of 'UltravexTM' - (Halobetasol)
Dr. Reddy's launches RedituxT - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
Dr. Reddy’s announces the launch of Zolpidem Tartrate tablets
Dr. Reddy’s launches ‘Alfoo’ for rapid relief from signs & symptoms of BPH
Dr. Reddy’s launches Levofloxacin branded as 'LEON'
Dr. Reddy’s launches ‘Doxobid’ – a new oral bronchodilator for asthma & COPD
Dr. Reddy’s launches ‘Z & D’ – Zinc therapy for effective management of diarrhea
Dr. Reddy's launches ‘Viboliv’ - (Metadoxine) to enter the hepatoprotectives market
Dr. Reddy's launches ‘Shadowz' a unique high SPF protection sunscreen
Dr. Reddys launches India's first drug for treatment of diabetic foot ulcers
Dr. Reddy's launches new treatment modality for Osteoarthritis
Dr. Reddy's launches new treatment for acute diarrhea
Dr. Reddy's launches Oral Rehydration Solution (Rebalanz)
Dr. Reddy's launches Eco friendly treatment (Econorm)
Dr. Reddy's launches Venusia for velvet like skin
Dr. Reddy's launches a novel immune booster for children Product launched in collaboration with Symbiotics of New Zealand
Best Sellers
Branded Formulations
Annual Report 2007
Download Brochures
Press Releases
|
Business Development
|
Opportunities
|
Investors
|
Site map
|
Accessibility Statement
Designed by
© 2001 - 2008 Dr. Reddy's Laboratories Ltd. All rights reserved
Site best viewed at 800x600 resolution
